United States · FDA National Drug Code directory
Topcare ClearLax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 36800-306_05d0b5e4-4bde-4c30-8742-f8e7f8e5859c
- Product NDC
- 36800-306
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- Topco Associates LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091007
- Source listing expiry
- 20271231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 119 g in 1 BOTTLE (36800-306-01) · 36800-306-01
- 238 g in 1 BOTTLE (36800-306-02) · 36800-306-02
- 507 g in 1 BOTTLE (36800-306-03) · 36800-306-03
- 765 g in 1 BOTTLE (36800-306-09) · 36800-306-09
- 595 g in 1 BOTTLE (36800-306-19) · 36800-306-19
- 2 BOTTLE in 1 PACKAGE (36800-306-20) / 850 g in 1 BOTTLE · 36800-306-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →